Literature DB >> 20145042

Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer.

Giridhar Mudduluru1, Peter Vajkoczy, Heike Allgayer.   

Abstract

Myeloid zinc finger 1 (MZF1) is a member of the SCAN domain family transcription factors that form dimers through their highly conserved SCAN motifs. Silencing of MZF1 inhibits cell proliferation, and abnormal expression of MZF1 results in cancer development. However, a potential role of MZF1 in metastasis remains unclear. Axl is a receptor tyrosine kinase and was first identified as a transforming gene in chronic myeloid leukemia. Axl overexpression induces proliferation, migration, and invasion and is highly expressed in different human cancers. In this study, we show that overexpression of MZF1 induces migration and invasion in colorectal (Rko, SW480) and cervical (HeLa) cancer cells. In addition, we show that MZF1 binds to the Axl promoter, transactivates promoter activity, and enhances Axl-mRNA and protein expression in a dose-dependent manner. In vitro, sh-RNA knockdown of Axl reduced MZF1-induced migration and invasion in HeLa and Rko cells (P = 0.05). Additionally, Rko cells overexpressing MZF1 showed increased tumor formation and liver metastasis in the chicken-embryo-metastasis assay in vivo. Furthermore, the expression of MZF1 and Axl was significantly higher in resected colorectal tumors compared with corresponding normal tissues (P = 0.02; P = 0.05), and MZF1 expression was positively correlated with Axl gene expression in tumor tissues (P < 0.01). Taken together, this is the first study to show that MZF1 induces invasion and in vivo metastasis in colorectal and cervical cancer, at least in part by regulating Axl gene expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145042     DOI: 10.1158/1541-7786.MCR-09-0326

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  55 in total

1.  Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma.

Authors:  Chung-Po Ko; Li-Chiu Yang; Chih-Jung Chen; Kun-Tu Yeh; Shu-Hui Lin; Shun-Fa Yang; Mu-Kuan Chen; Chiao-Wen Lin
Journal:  Tumour Biol       Date:  2015-04-16

Review 2.  TYRO3: A potential therapeutic target in cancer.

Authors:  Pei-Ling Hsu; Jonathan Jou; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-02

Review 3.  The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Authors:  Rhonda L Bitting; Daneen Schaeffer; Jason A Somarelli; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 4.  Axl-dependent signalling: a clinical update.

Authors:  Vyacheslav A Korshunov
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

5.  CXCR4 Expression and Treatment with SDF-1α or Plerixafor Modulate Proliferation and Chemosensitivity of Colon Cancer Cells.

Authors:  Doreen Heckmann; Patrick Maier; Stephanie Laufs; Frederik Wenz; W Jens Zeller; Stefan Fruehauf; Heike Allgayer
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

6.  TAM receptors in leukemia: expression, signaling, and therapeutic implications.

Authors:  Luis Brandão; Justine Migdall-Wilson; Kristen Eisenman; Douglas K Graham
Journal:  Crit Rev Oncog       Date:  2011

7.  MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).

Authors:  Salvador Meseguer; Giridhar Mudduluru; Juan Manuel Escamilla; Heike Allgayer; Domingo Barettino
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

8.  The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility.

Authors:  Shuling Zhang; Wei Shi; Edward S Ramsay; Valery Bliskovsky; Adrian Max Eiden; Daniel Connors; Matthew Steinsaltz; Wendy DuBois; Beverly A Mock
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

9.  Malignant human cell transformation of Marcellus Shale gas drilling flow back water.

Authors:  Yixin Yao; Tingting Chen; Steven S Shen; Yingmei Niu; Thomas L DesMarais; Reka Linn; Eric Saunders; Zhihua Fan; Paul Lioy; Thomas Kluz; Lung-Chi Chen; Zhuangchun Wu; Max Costa; Judith Zelikoff
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-22       Impact factor: 4.219

10.  Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.

Authors:  Y Chen; Z Zhang; K Yang; J Du; Y Xu; S Liu
Journal:  Oncogene       Date:  2014-10-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.